Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]

INTRODUCTION: The aim of this study was to assess the efficacy of two dosing schedules of recombinant human erythropoietin (rHuEPO) in increasing haematocrit (Hct) and haemoglobin (Hb) and reducing exposure to allogeneic red blood cell (RBC) transfusion in critically ill patients. METHOD: This was a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Georgopoulos, Dimitris, Matamis, Dimitris, Routsi, Christina, Michalopoulos, Argiris, Maggina, Nina, Dimopoulos, George, Zakynthinos, Epaminondas, Nakos, George, Thomopoulos, George, Mandragos, Kostas, Maniatis, Alice
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2005
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1297615/
https://ncbi.nlm.nih.gov/pubmed/16277712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc3786
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak